Use of trimethoprim-sulfamethoxazole in external otitis.
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001414:Bacitracin / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004341:Drug Evaluation; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone; D007223:Infant; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use; D009824:Ointments; D010032:Otitis Externa / Q000188:drug therapy*; D011113:Polymyxins / Q000008:administration & dosage / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014295:Trimethoprim / Q000008:administration & dosage / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D009824:Ointments; D011113:Polymyxins; D001414:Bacitracin; D014295:Trimethoprim; D009355:Neomycin; D013420:Sulfamethoxazole; D006854:Hydrocortisone